Brind.
  1. A company with a subsidiary in the Netherlands sold it to AVS Bio, using the proceeds to invest in an AI-based SaaS platform.

News originated from MIaMI in the Netherlands, leading to an AAIC conference in Toronto, involving Broadway.

1 report, 1 independent Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

News originated from MIaMI in the Netherlands, leading to an AAIC conference in Toronto, involving Broadway.

Who's involved

What this event is mainly about
MIaMINetherlands

Keep exploring

Part of

A company with a subsidiary in the Netherlands sold it to AVS Bio, using the proceeds to invest in an AI-based SaaS platform. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireNewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer’s Disease Biomarkers at AAIC 2025 -- Pre-specified analysis shows ob